SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Grace Hui-Min Wu, Anssi Auvinen, Amy Ming-Fang Yen, Matti Hakama, Teuvo L. Tammela, Ulf-Håkan Stenman, Paula Kujala, Mirja Ruutu, Hsiu-Hsi Chen, The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific Antigen, European Urology, 2012, 61, 5, 1011

    CrossRef

  2. 2
    Stacy Loeb, Herbert Ballentine Carter, Campbell-Walsh Urology, 2012,

    CrossRef

  3. 3
    Xiaoye Zhu, Pim J. van Leeuwen, Meelan Bul, Suzie J. Otto, Harry J. de Koning, Chris H. Bangma, Fritz H. Schröder, Monique J. Roobol, Disease-Specific Survival of Men With Prostate Cancer Detected During the Screening Interval: Results of the European Randomized Study of Screening for Prostate Cancer–Rotterdam After 11 Years of Follow-Up, European Urology, 2011, 60, 2, 330

    CrossRef

  4. 4
    Pim J. van Leeuwen, David Connolly, Teuvo L. J. Tammela, Anssi Auvinen, Ries Kranse, Monique J. Roobol, Fritz H. Schroder, Anna Gavin, Balancing the harms and benefits of early detection of prostate cancer, Cancer, 2010, 116, 20
  5. 5
    Roderick C. N. van den Bergh, Ewout W. Steyerberg, Ali Khatami, Gunnar Aus, Carl Gustaf Pihl, Tineke Wolters, Pim J. van Leeuwen, Monique J. Roobol, Fritz H. Schröder, Jonas Hugosson, Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?, Cancer, 2010, 116, 5
  6. 6
    Chris H. Bangma, Ron H. van Schaik, Bert G. Blijenberg, Monique J. Roobol, Hans Lilja, Ulf-Håkan Stenman, On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer, European Journal of Cancer, 2010, 46, 17, 3109

    CrossRef

  7. 7
    William R. Carpenter, Daniel L. Howard, Yhenneko J. Taylor, Louie E. Ross, Sara E. Wobker, Paul A. Godley, Racial differences in PSA screening interval and stage at diagnosis, Cancer Causes & Control, 2010, 21, 7, 1071

    CrossRef

  8. 8
    P J van Leeuwen, H A van Vugt, C H Bangma, The implementation of screening for prostate cancer, Prostate Cancer and Prostatic Diseases, 2010, 13, 3, 218

    CrossRef

  9. 9
    Fritz H. Schröder, Screening for prostate cancer (PC)—an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC), Urologic Oncology: Seminars and Original Investigations, 2008, 26, 5, 533

    CrossRef

  10. 10
    Sigrid Carlsson, Gunnar Aus, Catrin Wessman, Jonas Hugosson, Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) – Results from a prospective, population-based, randomised study, European Journal of Cancer, 2007, 43, 14, 2109

    CrossRef

  11. You have free access to this content11
    Seyyed Yousof Hosseini, Massood Moharramzadeh, Ali Reza Ghadian, Hassan Hooshyar, Ali Reza Lashay, Mohammah Reza Safarinejad, Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran, International Journal of Urology, 2007, 14, 5
  12. 12
    Khatami Ali, Aus Gunnar, Damber Jan-Erik, Lilja Hans, Lodding Pär, Hugosson Jonas, PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: Results from the European randomized study of screening for prostate cancer, Sweden section, International Journal of Cancer, 2007, 120, 1
  13. 13
    J Melia, D Dearnaley, S Moss, L Johns, P Coulson, C Moynihan, J Sweetman, M C Parkinson, R Eeles, M Watson, The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk, British Journal of Cancer, 2006, 94, 4, 499

    CrossRef

  14. 14
    V. Lent, F. Baumbusch, G. Weber, Behandlungsfehler im Zusammenhang mit der Bestimmung des prostataspezifischen Antigens, Der Urologe, 2005, 44, 12, 1458

    CrossRef

  15. 15
    R. Postma, F.H. Schröder, Screening for prostate cancer, European Journal of Cancer, 2005, 41, 6, 825

    CrossRef